Hverken MNS eller rhabdomyolyse er rapporteret i forbindelse med entakaponbehandling i kliniske afprøvninger, hvor entakapon blev seponeret pludseligt.
Neither NMS nor rhabdomyolysis have been reported in association with entacapone treatment from controlled trials in which entacapone was discontinued abruptly.